Market Cap 2.13M
Revenue (ttm) 0.00
Net Income (ttm) -18.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 361,500
Avg Vol 1,843,672
Day's Range N/A - N/A
Shares Out 4.77M
Stochastic %K 43%
Beta 0.85
Analysts Strong Buy
Price Target $36.00

Latest News on ENTO

Entero Therapeutics Appoints Richard Paolone as CEO

Feb 14, 2025, 4:00 PM EST - 4 months ago

Entero Therapeutics Appoints Richard Paolone as CEO